Faculty

Ruanne Barnabas

Adjunct Professor, Epidemiology
Professor, Global Health
Professor, Medicine - Allergy and Infectious Dis.

206-520-3813
rbarnaba@uw.edu

Education

DPhil Epidemiology, University of Oxford, 2005
MSc Epidemiology, University of Oxford, 2000
MBChB Medicine & Surgery, University of Cape Town (South Africa), 1997

Contact

206-520-3813
rbarnaba@uw.edu

Box 359927
325 Ninth Ave
Seattle, WA 98104

Bio

Ruanne Barnabas is an Associate Professor in Global Health and Medicine at the University of Washington and affiliate at the Fred Hutchinson Cancer Research Center. She is a South African Physician-Epidemiologist. Her research focuses on interventions for HIV and STD treatment and prevention, and, more recently on COVID-19 prevention. She is the protocol chair of the Delivery Optimization for antiretroviral (DO ART) Study, which will evaluate the effectiveness and cost-effectiveness of decentralized, community-based ART initiation compared to clinic- based care. Also, she is the Principle Investigator for the COVID-19 PEP Study. She is the protocol chair for the Kenya Single-dose HPV vaccine Efficacy (KEN SHE) Study, which will evaluate the efficacy of single-dose HPV vaccination for women. She leads the cost-effectiveness evaluation of other projects including scale-up of cervical cancer and HIV treatment and prevention in high burden settings. Her projects use clinical trial data and health economic modeling to estimate the potential impact of interventions. The ultimate aim of her work is to identify effective and efficient treatment and prevention public health strategies.

Recent Publications (PubMed)

Implementation of HIV Self-Testing to Reach Men in Rural uMkhanyakude, KwaZulu-Natal, South Africa. a DO-ART Trial Sub Study.
(2021)
Front Public Health 9(): 652887
Sithole N, Shahmanesh M, Koole O, Krows M, Schaafsma T, Siedner MJ, Celum C, Barnabas RV, Shapiro AE

Low costs and opportunities for efficiency: a cost analysis of the first year of programmatic PrEP delivery in Kenya's public sector.
(2021 Aug 16)
BMC Health Serv Res 21(1): 823
Peebles K, Mugwanya KK, Irungu E, Odoyo J, Wamoni E, Morton JF, Ngure K, Bukusi EA, Mugo NR, Masyuko S, Mukui I, Baeten JM, Barnabas RV, Partners Scale-Up Project Team.

Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19.
(2021 Sep 23)
N Engl J Med 385(13): 1184-1195
O'Brien MP, Forleo-Neto E, Musser BJ, Isa F, Chan KC, Sarkar N, Bar KJ, Barnabas RV, Barouch DH, Cohen MS, Hurt CB, Burwen DR, Marovich MA, Hou P, Heirman I, Davis JD, Turner KC, Ramesh D, Mahmood A, Hooper AT, Hamilton JD, Kim Y, Purcell LA, Baum A, Kyratsous CA, Krainson J, Perez-Perez R, Mohseni R, Kowal B, DiCioccio AT, Stahl N, Lipsich L, Braunstein N, Herman G, Yancopoulos GD, Weinreich DM, Covid-19 Phase 3 Prevention Trial Team.

The Community PrEP Study: a randomized control trial leveraging community-based platforms to improve access and adherence to pre-exposure prophylaxis to prevent HIV among adolescent girls and young women in South Africa-study protocol.
(2021 Jul 26)
Trials 22(1): 489
Medina-Marino A, Bezuidenhout D, Hosek S, Barnabas RV, Atujuna M, Bezuidenhout C, Ngwepe P, Peters RPH, Little F, Celum CL, Daniels J, Bekker LG

A Framework for Cervical Cancer Elimination in Low-and-Middle-Income Countries: A Scoping Review and Roadmap for Interventions and Research Priorities.
(2021)
Front Public Health 9(): 670032
Shin MB, Liu G, Mugo N, Garcia PJ, Rao DW, Bayer CJ, Eckert LO, Pinder LF, Wasserheit JN, Barnabas RV

Show complete publication list